National Life Insurance PLC (DSE:NATLIFEINS)
85.30
-1.40 (-1.61%)
At close: Dec 4, 2025
National Life Insurance Income Statement
Financials in millions BDT. Fiscal year is January - December.
Millions BDT. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Premiums & Annuity Revenue | 22,605 | 21,017 | 18,628 | 16,105 | 14,154 | 11,970 | Upgrade
|
| Total Interest & Dividend Income | 5,086 | 4,634 | 3,741 | 3,463 | 3,424 | 3,420 | Upgrade
|
| Other Revenue | 55 | 56.9 | 60.24 | 104.1 | 162.37 | 68.04 | Upgrade
|
| Total Revenue | 27,746 | 25,708 | 22,429 | 19,671 | 17,741 | 15,458 | Upgrade
|
| Revenue Growth (YoY) | 11.32% | 14.62% | 14.02% | 10.88% | 14.77% | 10.07% | Upgrade
|
| Policy Benefits | 13,478 | 12,043 | 11,008 | 10,521 | 8,815 | 7,989 | Upgrade
|
| Policy Acquisition & Underwriting Costs | 3,336 | 3,121 | 2,836 | 2,397 | 2,251 | 1,859 | Upgrade
|
| Depreciation & Amortization | 182.89 | 189.1 | 163.98 | 142.16 | 128.26 | 130.89 | Upgrade
|
| Selling, General & Administrative | 881.38 | 826.73 | 673.13 | 583.32 | 490.66 | 411.43 | Upgrade
|
| Other Operating Expenses | 29.49 | 28.04 | 13.4 | 9.93 | 21.34 | 31.31 | Upgrade
|
| Total Operating Expenses | 19,704 | 17,925 | 16,348 | 14,934 | 12,912 | 11,597 | Upgrade
|
| Operating Income | 8,042 | 7,782 | 6,080 | 4,738 | 4,829 | 3,861 | Upgrade
|
| Interest Expense | -8.19 | -7.41 | -5.27 | -8.21 | -8.11 | -6.94 | Upgrade
|
| Other Non Operating Income (Expenses) | -99.92 | -104.76 | -114.83 | -85.83 | -102.94 | -44.29 | Upgrade
|
| EBT Excluding Unusual Items | 7,934 | 7,670 | 5,960 | 4,644 | 4,718 | 3,810 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.95 | 1.78 | 0.16 | 300.47 | 0.31 | 0.12 | Upgrade
|
| Other Unusual Items | - | - | - | - | -5 | - | Upgrade
|
| Pretax Income | 7,936 | 7,672 | 5,960 | 4,944 | 4,713 | 3,810 | Upgrade
|
| Income Tax Expense | 269.97 | 278.49 | 537.45 | 356.81 | 481.92 | 362.15 | Upgrade
|
| Earnings From Continuing Ops. | 7,666 | 7,393 | 5,423 | 4,587 | 4,231 | 3,448 | Upgrade
|
| Minority Interest in Earnings | 0.1 | -0.87 | -1.08 | -2.69 | -3.77 | -2.25 | Upgrade
|
| Net Income | 7,666 | 7,393 | 5,422 | 4,585 | 4,227 | 3,446 | Upgrade
|
| Net Income to Common | 7,666 | 7,393 | 5,422 | 4,585 | 4,227 | 3,446 | Upgrade
|
| Net Income Growth | -0.49% | 36.35% | 18.26% | 8.46% | 22.68% | 25.39% | Upgrade
|
| Shares Outstanding (Basic) | 109 | 109 | 109 | 109 | 109 | 109 | Upgrade
|
| Shares Outstanding (Diluted) | 109 | 109 | 109 | 109 | 109 | 109 | Upgrade
|
| EPS (Basic) | 70.64 | 68.12 | 49.96 | 42.25 | 38.95 | 31.75 | Upgrade
|
| EPS (Diluted) | 70.64 | 68.12 | 49.96 | 42.25 | 38.95 | 31.75 | Upgrade
|
| EPS Growth | -0.49% | 36.35% | 18.26% | 8.46% | 22.68% | 25.39% | Upgrade
|
| Free Cash Flow | 5,252 | 6,350 | 4,761 | 2,448 | 3,945 | 4,366 | Upgrade
|
| Free Cash Flow Per Share | 48.39 | 58.51 | 43.87 | 22.56 | 36.35 | 40.23 | Upgrade
|
| Dividend Per Share | 3.500 | 3.500 | 3.800 | 3.800 | 3.500 | 3.200 | Upgrade
|
| Dividend Growth | -7.90% | -7.90% | - | 8.57% | 9.38% | 14.29% | Upgrade
|
| Operating Margin | 28.98% | 30.27% | 27.11% | 24.09% | 27.22% | 24.98% | Upgrade
|
| Profit Margin | 27.63% | 28.76% | 24.17% | 23.31% | 23.83% | 22.29% | Upgrade
|
| Free Cash Flow Margin | 18.93% | 24.70% | 21.23% | 12.45% | 22.24% | 28.24% | Upgrade
|
| EBITDA | 8,151 | 7,897 | 6,174 | 4,818 | 4,898 | 3,935 | Upgrade
|
| EBITDA Margin | 29.38% | 30.72% | 27.53% | 24.49% | 27.61% | 25.45% | Upgrade
|
| D&A For EBITDA | 108.77 | 114.97 | 93.54 | 80.23 | 69.33 | 73.21 | Upgrade
|
| EBIT | 8,042 | 7,782 | 6,080 | 4,738 | 4,829 | 3,861 | Upgrade
|
| EBIT Margin | 28.98% | 30.27% | 27.11% | 24.09% | 27.22% | 24.98% | Upgrade
|
| Effective Tax Rate | 3.40% | 3.63% | 9.02% | 7.22% | 10.22% | 9.50% | Upgrade
|
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.